With over 18 subspecialties and 60+ experts, we can help with even the most difficult cases.
NEWS & EVENTS
Nature Study Reveals a New Weakness in Aggressive Pediatric Brain Tumors
A team of researchers from the University of Michigan Department of Pathology has identified a previously unknown vulnerability in one of the most aggressive forms of pediatric brain cancer, opening the door to potential new treatment strategies for children with limited therapeutic options.
Discontinuation of the 1p/19q Deletion by FISH Assay
Effective September 30, 2026, the 1p/19q Deletion by FISH assay will be discontinued. To assess for 1p/19q co-deletion, laboratories should order Cytogenetics, Chromosomal Microarray Analysis, FFPE Tissue (order code: CGAPT).
Drs. Simon Hogan and Nicholas Lukacs Receive Strategic Initiative Fund Award to Establish Michigan Center for Human Immunology Model Systems (Mi-CHIM)
Anew University of Michigan initiative aims to address one of biomedical research’s most persistent challenges: why therapies that succeed in animal models often fail in human patients. Now, a new initiative led by Drs. Simon P. Hogan, the Askwith Research Professor of Food Allergy, Mary H. Weiser Food Allergy Center and Professor of Pathology, and Nicholas W. Lukacs, the Godfrey Dorr Stobbe Professor of Pathology and interim Director of the Mary H. Weiser Food Allergy Center, aims to help close that gap.
